LLY vs XOMAP: Which Is the Better Dividend Stock?
As of July 2026, LLY (Eli Lilly and Company) screens as the stronger dividend stock, winning 4 of 6 head-to-head metrics. XOMAP offers the higher yield at 8.63%, LLY has the higher dividend-safety score, and XOMAP trades at the larger discount to fair value (+82%).
| Metric | LLY | XOMAP |
|---|---|---|
| Forward yield | 0.59% | 8.63% |
| Annual dividend | $6.92 | $2.16 |
| Payout ratio | 22% | — |
| Years of growth | 11 yr | 0 yr |
| 5-yr dividend growth | 15.2% | — |
| 5-yr total return | 357% | -5% |
| Dividend safety score | 94 (A) | 75 (B) |
| Fair value estimate | $994.52 | $45.50 |
| Upside to fair value | -16% | +82% |
| Frequency | quarterly | monthly |
| Market cap | $1.0T | — |
| P/E ratio | 41.8 | 24.9 |
Higher yield
XOMAP
8.63%
Safer dividend
LLY
Grade A
Faster growth
LLY
15.2%
Better value
XOMAP
+82% upside
LLY vs XOMAP — FAQ
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.